Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MY3C
|
|||
| Former ID |
DIB007108
|
|||
| Drug Name |
AR08
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Phase 2 | [1] | |
| Company |
Arbor pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Adrenergic receptor (ADR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01876719) AR08 for Treatment of ADHD in Children. U.S. National Institutes of Health. | |||
| REF 2 | Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal. Expert Opin Drug Discov. 2014 June; 9(6): 579-594. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.